Remove australia-news health
article thumbnail

Medicines for migraines, reflux and cancer to become cheaper in Australia

The Guardian - Pharmaceutical Industry

The health minister, Mark Butler, on Monday announced Australians will have expanded access to some medicines from 1 October, saving $130m a year in out-of-pocket costs.

65
article thumbnail

‘Looming global health crisis’: urgent action needed to prevent spread of drug-resistant superbugs, CSIRO says

The Guardian - Pharmaceutical Industry

Sign up for Guardian Australia’s free morning and afternoon email newsletters for your daily news roundup Continue reading.

65
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cancer researchers unable to access clinical trial data for top-selling drugs, study finds

The Guardian - Pharmaceutical Industry

The authors of a study published in the journal JAMA Oncology on Friday said the lack of transparency should be concerning to Australia. Sign up to receive an email with the top stories from Guardian Australia every morning Continue reading.

article thumbnail

GSK Reports the US FDA Acceptance of sBLA for Jemperli (dostarlimab) to Treat dMMR/MSI-H Primary Advanced or Recurrent Endometrial Cancer

PharmaShots

The sBLA of dostarlimab will be reviewed by health authorities in the US, Australia, Canada, Switzerland, Singapore & the UK under the Project Orbis Ref: GSK | Image: GSK Related News:- GSK Reports EMA’s Validation of MAA for Jemperli (dostarlimab) to Treat dMMR/MSI-H Primary Advanced or Recurrent Endometrial Cancer PharmaShots!

FDA 40
article thumbnail

UK, Moderna formalise 10-year vaccines alliance

pharmaphorum

The first vaccines are due to be produced at the new facility in 2025. The biotech will also work with the UK Health Security Agency (UKHSA) to ensure early vaccine development against emerging threats, in a bid to get from “variant to vaccine” within 100 days.

Vaccines 122
article thumbnail

Abbott Receives the US FDA and EU Approvals for Ablation Technologies to Treat Abnormal Heart Rhythms

PharmaShots

The device is now approved as a treatment option for ventricular tachycardia (VT) in patients with non-ischemic cardiomyopathy The decision was based on the (LESS-VT) study in 600 adult patients who were randomized to either undergo treatment with a previously approved ablation device or the FlexAbility SE Ablation Catheter which showed that 80% of (..)

FDA 40
article thumbnail

Will We Have a Bad Flu Season This Year?

The People's Pharmacy

The answer is AUSTRALIA! We often look to Australia for signs of the coming flu season. That’s because flu season is always six months ahead in Australia and New Zealand. The H3N2 type-A strain of influenza increased sharply in Australia (aka Oz) in early May and peaked there in mid-June. Guest what?